Patients The state of women’s health in the UK: A parliamentary round... The UK faces one of the largest gender health gaps among G20 nations and women’s health challenges remain significantly, unacceptably underserved.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face